AllianceBernstein’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

AllianceBernstein’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-18,375	Closed	-$1.1M	–	3539
2021 Q1	$1.1M	Buy	+18,375	New	+$665K	﹤0.01%	2369

AllianceBernstein's PAND Position: Q2 2021 in Review

AllianceBernstein sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 18,375 shares — an estimated $1.1M sold.

AllianceBernstein first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $1.1M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

AllianceBernstein reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
AllianceBernstein sold 18,375 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $1.1M.
AllianceBernstein first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
AllianceBernstein's Pandion Therapeutics Inc. Common Stock position peaked at $1.1M in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on AllianceBernstein's 13F filing for Q2 2021, filed 30 Jul 2021.